nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Imiquimod—skin cancer	0.324	0.452	CbGbCtD
Phenylephrine—CYP1A2—Vemurafenib—skin cancer	0.178	0.248	CbGbCtD
Phenylephrine—CYP1A2—Dacarbazine—skin cancer	0.136	0.19	CbGbCtD
Phenylephrine—CYP1A2—Fluorouracil—skin cancer	0.0799	0.111	CbGbCtD
Phenylephrine—Arteriospasm coronary—Fluorouracil—skin cancer	0.0151	0.0536	CcSEcCtD
Phenylephrine—Eye infection—Imiquimod—skin cancer	0.0128	0.0455	CcSEcCtD
Phenylephrine—Ischaemia—Imiquimod—skin cancer	0.0109	0.0386	CcSEcCtD
Phenylephrine—Rales—Bleomycin—skin cancer	0.00688	0.0244	CcSEcCtD
Phenylephrine—Abdominal pain upper—Vismodegib—skin cancer	0.005	0.0177	CcSEcCtD
Phenylephrine—Stinging—Imiquimod—skin cancer	0.00491	0.0174	CcSEcCtD
Phenylephrine—Skin exfoliation—Imiquimod—skin cancer	0.00379	0.0135	CcSEcCtD
Phenylephrine—Lacrimation—Fluorouracil—skin cancer	0.00373	0.0132	CcSEcCtD
Phenylephrine—Pulmonary oedema—Imiquimod—skin cancer	0.00354	0.0125	CcSEcCtD
Phenylephrine—Extravasation—Bleomycin—skin cancer	0.00324	0.0115	CcSEcCtD
Phenylephrine—Dysgeusia—Vismodegib—skin cancer	0.00323	0.0115	CcSEcCtD
Phenylephrine—Extravasation—Dactinomycin—skin cancer	0.00302	0.0107	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00279	0.00989	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Fluorouracil—skin cancer	0.00273	0.00968	CcSEcCtD
Phenylephrine—Stinging—Fluorouracil—skin cancer	0.00271	0.00961	CcSEcCtD
Phenylephrine—Skin exfoliation—Bleomycin—skin cancer	0.0027	0.00956	CcSEcCtD
Phenylephrine—Lacrimation—Docetaxel—skin cancer	0.00269	0.00955	CcSEcCtD
Phenylephrine—Nervous system disorder—Vismodegib—skin cancer	0.00264	0.00936	CcSEcCtD
Phenylephrine—Skin disorder—Vismodegib—skin cancer	0.00261	0.00927	CcSEcCtD
Phenylephrine—Eye irritation—Fluorouracil—skin cancer	0.00257	0.00912	CcSEcCtD
Phenylephrine—Extravasation—Fluorouracil—skin cancer	0.00252	0.00892	CcSEcCtD
Phenylephrine—Sweating increased—Imiquimod—skin cancer	0.00243	0.00862	CcSEcCtD
Phenylephrine—Lacrimation increased—Fluorouracil—skin cancer	0.00238	0.00845	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00232	0.00824	CcSEcCtD
Phenylephrine—Pain—Vismodegib—skin cancer	0.0023	0.00816	CcSEcCtD
Phenylephrine—Skin exfoliation—Temozolomide—skin cancer	0.00227	0.00807	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Imiquimod—skin cancer	0.00219	0.00777	CcSEcCtD
Phenylephrine—Myocardial infarction—Imiquimod—skin cancer	0.00218	0.00773	CcSEcCtD
Phenylephrine—Cardiac disorder—Vemurafenib—skin cancer	0.00217	0.0077	CcSEcCtD
Phenylephrine—Angiopathy—Vemurafenib—skin cancer	0.00212	0.00753	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vemurafenib—skin cancer	0.00211	0.00748	CcSEcCtD
Phenylephrine—Photophobia—Fluorouracil—skin cancer	0.00206	0.00731	CcSEcCtD
Phenylephrine—Dysgeusia—Vemurafenib—skin cancer	0.002	0.00708	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Docetaxel—skin cancer	0.00197	0.00699	CcSEcCtD
Phenylephrine—Visual impairment—Imiquimod—skin cancer	0.00192	0.00682	CcSEcCtD
Phenylephrine—Eye pain—Temozolomide—skin cancer	0.00192	0.00679	CcSEcCtD
Phenylephrine—Pruritus—Vismodegib—skin cancer	0.0019	0.00675	CcSEcCtD
Phenylephrine—Eye irritation—Docetaxel—skin cancer	0.00186	0.00658	CcSEcCtD
Phenylephrine—Extravasation—Docetaxel—skin cancer	0.00182	0.00644	CcSEcCtD
Phenylephrine—Angiopathy—Imiquimod—skin cancer	0.00181	0.00642	CcSEcCtD
Phenylephrine—Immune system disorder—Imiquimod—skin cancer	0.0018	0.00639	CcSEcCtD
Phenylephrine—Mediastinal disorder—Imiquimod—skin cancer	0.0018	0.00638	CcSEcCtD
Phenylephrine—Arrhythmia—Imiquimod—skin cancer	0.00178	0.00632	CcSEcCtD
Phenylephrine—Mental disorder—Imiquimod—skin cancer	0.00175	0.0062	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00172	0.00611	CcSEcCtD
Phenylephrine—Lacrimation increased—Docetaxel—skin cancer	0.00172	0.0061	CcSEcCtD
Phenylephrine—Vomiting—Vismodegib—skin cancer	0.00171	0.00607	CcSEcCtD
Phenylephrine—Rash—Vismodegib—skin cancer	0.0017	0.00602	CcSEcCtD
Phenylephrine—Dermatitis—Vismodegib—skin cancer	0.0017	0.00601	CcSEcCtD
Phenylephrine—Nervous system disorder—Vemurafenib—skin cancer	0.00163	0.00578	CcSEcCtD
Phenylephrine—Skin disorder—Vemurafenib—skin cancer	0.00162	0.00573	CcSEcCtD
Phenylephrine—Nausea—Vismodegib—skin cancer	0.0016	0.00567	CcSEcCtD
Phenylephrine—Agitation—Imiquimod—skin cancer	0.0016	0.00566	CcSEcCtD
Phenylephrine—Blood pressure increased—Docetaxel—skin cancer	0.00158	0.00562	CcSEcCtD
Phenylephrine—Syncope—Imiquimod—skin cancer	0.00156	0.00553	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Bleomycin—skin cancer	0.00156	0.00552	CcSEcCtD
Phenylephrine—Myocardial infarction—Bleomycin—skin cancer	0.00155	0.00549	CcSEcCtD
Phenylephrine—Palpitations—Imiquimod—skin cancer	0.00154	0.00545	CcSEcCtD
Phenylephrine—Loss of consciousness—Imiquimod—skin cancer	0.00153	0.00542	CcSEcCtD
Phenylephrine—Skin exfoliation—Docetaxel—skin cancer	0.00151	0.00536	CcSEcCtD
Phenylephrine—Hypertension—Imiquimod—skin cancer	0.0015	0.00532	CcSEcCtD
Phenylephrine—Chest pain—Imiquimod—skin cancer	0.00148	0.00525	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00147	0.00521	CcSEcCtD
Phenylephrine—Sweating increased—Temozolomide—skin cancer	0.00146	0.00516	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00144	0.00509	CcSEcCtD
Phenylephrine—Pulmonary oedema—Docetaxel—skin cancer	0.00141	0.005	CcSEcCtD
Phenylephrine—Shock—Imiquimod—skin cancer	0.0014	0.00495	CcSEcCtD
Phenylephrine—Nervous system disorder—Imiquimod—skin cancer	0.00139	0.00493	CcSEcCtD
Phenylephrine—Tachycardia—Imiquimod—skin cancer	0.00138	0.00491	CcSEcCtD
Phenylephrine—Skin disorder—Imiquimod—skin cancer	0.00138	0.00489	CcSEcCtD
Phenylephrine—Hyperhidrosis—Imiquimod—skin cancer	0.00137	0.00486	CcSEcCtD
Phenylephrine—Paraesthesia—Imiquimod—skin cancer	0.00127	0.00452	CcSEcCtD
Phenylephrine—Dyspnoea—Imiquimod—skin cancer	0.00126	0.00448	CcSEcCtD
Phenylephrine—Hypersensitivity—Vemurafenib—skin cancer	0.00123	0.00435	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00122	0.00434	CcSEcCtD
Phenylephrine—Visual disturbance—Docetaxel—skin cancer	0.00121	0.0043	CcSEcCtD
Phenylephrine—Pain—Imiquimod—skin cancer	0.00121	0.0043	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Fluorouracil—skin cancer	0.00121	0.00429	CcSEcCtD
Phenylephrine—Myocardial infarction—Fluorouracil—skin cancer	0.0012	0.00427	CcSEcCtD
Phenylephrine—Pruritus—Vemurafenib—skin cancer	0.00118	0.00417	CcSEcCtD
Phenylephrine—Visual impairment—Temozolomide—skin cancer	0.00115	0.00409	CcSEcCtD
Phenylephrine—Urticaria—Imiquimod—skin cancer	0.00113	0.004	CcSEcCtD
Phenylephrine—Cardiac disorder—Temozolomide—skin cancer	0.00111	0.00394	CcSEcCtD
Phenylephrine—Dizziness—Vemurafenib—skin cancer	0.0011	0.0039	CcSEcCtD
Phenylephrine—Angiopathy—Temozolomide—skin cancer	0.00109	0.00385	CcSEcCtD
Phenylephrine—Immune system disorder—Temozolomide—skin cancer	0.00108	0.00383	CcSEcCtD
Phenylephrine—Mediastinal disorder—Temozolomide—skin cancer	0.00108	0.00382	CcSEcCtD
Phenylephrine—Vomiting—Vemurafenib—skin cancer	0.00106	0.00375	CcSEcCtD
Phenylephrine—Chest pain—Bleomycin—skin cancer	0.00105	0.00373	CcSEcCtD
Phenylephrine—Abdominal pain upper—Docetaxel—skin cancer	0.00105	0.00372	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Docetaxel—skin cancer	0.00105	0.00372	CcSEcCtD
Phenylephrine—Rash—Vemurafenib—skin cancer	0.00105	0.00372	CcSEcCtD
Phenylephrine—Mental disorder—Temozolomide—skin cancer	0.00105	0.00372	CcSEcCtD
Phenylephrine—Dermatitis—Vemurafenib—skin cancer	0.00105	0.00372	CcSEcCtD
Phenylephrine—Hypersensitivity—Imiquimod—skin cancer	0.00104	0.00371	CcSEcCtD
Phenylephrine—Headache—Vemurafenib—skin cancer	0.00104	0.00369	CcSEcCtD
Phenylephrine—Dysgeusia—Temozolomide—skin cancer	0.00102	0.00362	CcSEcCtD
Phenylephrine—Pruritus—Imiquimod—skin cancer	0.001	0.00356	CcSEcCtD
Phenylephrine—Nausea—Vemurafenib—skin cancer	0.000988	0.0035	CcSEcCtD
Phenylephrine—Arrhythmia—Fluorouracil—skin cancer	0.000985	0.00349	CcSEcCtD
Phenylephrine—Vision blurred—Temozolomide—skin cancer	0.000981	0.00348	CcSEcCtD
Phenylephrine—Tremor—Temozolomide—skin cancer	0.000976	0.00346	CcSEcCtD
Phenylephrine—Agitation—Temozolomide—skin cancer	0.000957	0.00339	CcSEcCtD
Phenylephrine—Dizziness—Imiquimod—skin cancer	0.000938	0.00333	CcSEcCtD
Phenylephrine—Palpitations—Temozolomide—skin cancer	0.00092	0.00326	CcSEcCtD
Phenylephrine—Paraesthesia—Bleomycin—skin cancer	0.000905	0.00321	CcSEcCtD
Phenylephrine—Vision blurred—Fluorouracil—skin cancer	0.000904	0.00321	CcSEcCtD
Phenylephrine—Vomiting—Imiquimod—skin cancer	0.000902	0.0032	CcSEcCtD
Phenylephrine—Hypertension—Temozolomide—skin cancer	0.000899	0.00319	CcSEcCtD
Phenylephrine—Dyspnoea—Bleomycin—skin cancer	0.000898	0.00319	CcSEcCtD
Phenylephrine—Rash—Imiquimod—skin cancer	0.000894	0.00317	CcSEcCtD
Phenylephrine—Dermatitis—Imiquimod—skin cancer	0.000893	0.00317	CcSEcCtD
Phenylephrine—Headache—Imiquimod—skin cancer	0.000888	0.00315	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00088	0.00312	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Docetaxel—skin cancer	0.000874	0.0031	CcSEcCtD
Phenylephrine—Myocardial infarction—Docetaxel—skin cancer	0.000869	0.00308	CcSEcCtD
Phenylephrine—Pain—Bleomycin—skin cancer	0.000862	0.00306	CcSEcCtD
Phenylephrine—Nausea—Imiquimod—skin cancer	0.000842	0.00299	CcSEcCtD
Phenylephrine—Nervous system disorder—Temozolomide—skin cancer	0.000833	0.00296	CcSEcCtD
Phenylephrine—Skin disorder—Temozolomide—skin cancer	0.000825	0.00293	CcSEcCtD
Phenylephrine—Hyperhidrosis—Temozolomide—skin cancer	0.000822	0.00291	CcSEcCtD
Phenylephrine—Chest pain—Fluorouracil—skin cancer	0.000817	0.0029	CcSEcCtD
Phenylephrine—Pain—Dactinomycin—skin cancer	0.000803	0.00285	CcSEcCtD
Phenylephrine—Urticaria—Bleomycin—skin cancer	0.0008	0.00284	CcSEcCtD
Phenylephrine—Nervous system disorder—Fluorouracil—skin cancer	0.000768	0.00272	CcSEcCtD
Phenylephrine—Visual impairment—Docetaxel—skin cancer	0.000767	0.00272	CcSEcCtD
Phenylephrine—Tachycardia—Fluorouracil—skin cancer	0.000764	0.00271	CcSEcCtD
Phenylephrine—Paraesthesia—Temozolomide—skin cancer	0.000763	0.00271	CcSEcCtD
Phenylephrine—Dyspnoea—Temozolomide—skin cancer	0.000758	0.00269	CcSEcCtD
Phenylephrine—Hypersensitivity—Bleomycin—skin cancer	0.000742	0.00263	CcSEcCtD
Phenylephrine—Cardiac disorder—Docetaxel—skin cancer	0.000738	0.00262	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000734	0.0026	CcSEcCtD
Phenylephrine—Pain—Temozolomide—skin cancer	0.000727	0.00258	CcSEcCtD
Phenylephrine—Angiopathy—Docetaxel—skin cancer	0.000722	0.00256	CcSEcCtD
Phenylephrine—Immune system disorder—Docetaxel—skin cancer	0.000718	0.00255	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—skin cancer	0.000717	0.00254	CcSEcCtD
Phenylephrine—Pruritus—Bleomycin—skin cancer	0.000713	0.00253	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—skin cancer	0.000711	0.00252	CcSEcCtD
Phenylephrine—Paraesthesia—Fluorouracil—skin cancer	0.000703	0.00249	CcSEcCtD
Phenylephrine—Dyspnoea—Fluorouracil—skin cancer	0.000698	0.00248	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—skin cancer	0.000697	0.00247	CcSEcCtD
Phenylephrine—Hypersensitivity—Dactinomycin—skin cancer	0.000692	0.00246	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—skin cancer	0.000678	0.00241	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000676	0.0024	CcSEcCtD
Phenylephrine—Urticaria—Temozolomide—skin cancer	0.000675	0.00239	CcSEcCtD
Phenylephrine—Pain—Fluorouracil—skin cancer	0.00067	0.00237	CcSEcCtD
Phenylephrine—Vomiting—Bleomycin—skin cancer	0.000641	0.00227	CcSEcCtD
Phenylephrine—Rash—Bleomycin—skin cancer	0.000635	0.00225	CcSEcCtD
Phenylephrine—Dermatitis—Bleomycin—skin cancer	0.000635	0.00225	CcSEcCtD
Phenylephrine—Hypersensitivity—Temozolomide—skin cancer	0.000626	0.00222	CcSEcCtD
Phenylephrine—Urticaria—Fluorouracil—skin cancer	0.000622	0.00221	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—skin cancer	0.000621	0.0022	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—skin cancer	0.000612	0.00217	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—skin cancer	0.000609	0.00216	CcSEcCtD
Phenylephrine—Pruritus—Temozolomide—skin cancer	0.000601	0.00213	CcSEcCtD
Phenylephrine—Nausea—Bleomycin—skin cancer	0.000598	0.00212	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—skin cancer	0.000598	0.00212	CcSEcCtD
Phenylephrine—Vomiting—Dactinomycin—skin cancer	0.000597	0.00212	CcSEcCtD
Phenylephrine—Rash—Dactinomycin—skin cancer	0.000592	0.0021	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—skin cancer	0.00059	0.00209	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000585	0.00208	CcSEcCtD
Phenylephrine—Hypersensitivity—Fluorouracil—skin cancer	0.000577	0.00205	CcSEcCtD
Phenylephrine—Dizziness—Temozolomide—skin cancer	0.000562	0.00199	CcSEcCtD
Phenylephrine—Nausea—Dactinomycin—skin cancer	0.000558	0.00198	CcSEcCtD
Phenylephrine—Shock—Docetaxel—skin cancer	0.000556	0.00197	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—skin cancer	0.000554	0.00197	CcSEcCtD
Phenylephrine—Pruritus—Fluorouracil—skin cancer	0.000554	0.00196	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—skin cancer	0.000552	0.00196	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—skin cancer	0.000549	0.00195	CcSEcCtD
Phenylephrine—Vomiting—Temozolomide—skin cancer	0.00054	0.00192	CcSEcCtD
Phenylephrine—Rash—Temozolomide—skin cancer	0.000536	0.0019	CcSEcCtD
Phenylephrine—Dermatitis—Temozolomide—skin cancer	0.000535	0.0019	CcSEcCtD
Phenylephrine—Headache—Temozolomide—skin cancer	0.000532	0.00189	CcSEcCtD
Phenylephrine—Dizziness—Fluorouracil—skin cancer	0.000518	0.00184	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—skin cancer	0.000507	0.0018	CcSEcCtD
Phenylephrine—Nausea—Temozolomide—skin cancer	0.000505	0.00179	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—skin cancer	0.000504	0.00179	CcSEcCtD
Phenylephrine—Vomiting—Fluorouracil—skin cancer	0.000498	0.00177	CcSEcCtD
Phenylephrine—Rash—Fluorouracil—skin cancer	0.000494	0.00175	CcSEcCtD
Phenylephrine—Dermatitis—Fluorouracil—skin cancer	0.000493	0.00175	CcSEcCtD
Phenylephrine—Headache—Fluorouracil—skin cancer	0.000491	0.00174	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000488	0.00173	CcSEcCtD
Phenylephrine—Pain—Docetaxel—skin cancer	0.000483	0.00171	CcSEcCtD
Phenylephrine—Nausea—Fluorouracil—skin cancer	0.000465	0.00165	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—skin cancer	0.000416	0.00148	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—skin cancer	0.0004	0.00142	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—skin cancer	0.000374	0.00133	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—skin cancer	0.000359	0.00127	CcSEcCtD
Phenylephrine—Rash—Docetaxel—skin cancer	0.000356	0.00126	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—skin cancer	0.000356	0.00126	CcSEcCtD
Phenylephrine—Headache—Docetaxel—skin cancer	0.000354	0.00126	CcSEcCtD
Phenylephrine—Nausea—Docetaxel—skin cancer	0.000336	0.00119	CcSEcCtD
